Novel therapies for Crohn disease and colitis

March 1997
CMAJ: Canadian Medical Association Journal;03/01/97, Vol. 156 Issue 5, p634
Academic Journal
No abstract available.


Related Articles

  • Crohn's disease.  // Columbia Electronic Encyclopedia, 6th Edition;Feb2013, p1 

    Crohn's disease: see colitis.

  • Crohn's disease.  // Columbia Electronic Encyclopedia, 6th Edition;Q1 2017, p1 

    Crohn's disease: see colitis.

  • Smoking status in therapeutic trials in Crohn's disease. McGovern, D. P. B.; Travis, S. P. L. // Gut;Jul2005, Vol. 54 Issue 7, p1047 

    Presents a letter to the editor on smoking status in trials of novel therapies for Crohn's disease.

  • The "Natural History" of Inflammatory Bowel Disease and Therapeutic Decisions. Janowitz, Henry D. // American Journal of Gastroenterology;Jun1987, Vol. 82 Issue 6, p498 

    Examines the effectiveness of therapeutics in treating inflammatory bowel disease. Effect of cortisone on ulcerative colitis according to a 1955 study by Truelove and Witts; Maintenance therapy in Crohn's disease; Impact of colectomy on ulcerative colitis.

  • Pharmacologic therapy for inflammatory bowel disease. Hirschfeld, Sondra; Clearfield, Harris R. // American Family Physician;6/1/1995, Vol. 51 Issue 8, p1971 

    Discusses the pharmacologic management of inflammatory bowel diseases, ulcerative colitis and Crohn's disease. Use of sulfasalazine; Development of 5-aminosalicylic acid (5-ASA); Topical therapy; Corticosteroid therapy; Antibiotic therapy; Immunosuppressive therapy.

  • Sulphasalazine for Crohn's Disease?  // British Medical Journal;5/10/1975, Vol. 2 Issue 5966, p297 

    Focuses on the use of sulphasalazine on the treatment of crohn's disease. Comparison of its effectivity on ulcerative colitis; Role in colonic inflammation; Limitation of therapy in adults.

  • New steroids for IBD: progress report. Hanauer, S.B. // Gut;Aug2002, Vol. 51 Issue 2, p182 

    Discusses the improvement of therapies for ulcerative colitis and Crohn's disease. Absorption efficiency of budenoside; Potency of non-systemic steroids; Efficacy of controlled release formulations.

  • Crohn's Colitis Comes of Age. Nugent, F. Warren // American Journal of Gastroenterology;Jun1975, Vol. 63 Issue 6, p471 

    Presents clinical information on Crohn's colitis. Differentiation between Crohn's colitis and ulcerative colitis; Symptoms associated with the disease; Radiologic characteristics of the disease; Recommended treatment for Crohn's colitis.

  • How to recognize and treat IBD. Lichtenstein, Gary R.; Hanauer, Stephen B.; Peppercorn, Mark A.; Ventura, Marissa // Patient Care;Dec2005, Vol. 39 Issue 12, p36 

    The article discusses how to recognize and treat inflammatory bowel disease (IBD). Crohn's disease and ulcerative colitis are the two most common forms of IBD. Most common presenting symptoms of ulcerative colitis are given. Different classes of drugs for treating IBD are discussed. Dietary and...

  • European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Travis, S. P. L.; Stange, E. F.; LĂ©mann, M.; Oresland, T.; Chowers, Y.; Forbes, A.; D'haens, G.; Kitis, G.; Cortot, A.; Prantera, C.; Marteau, P.; Colombel, J. -F.; Gionchetti, P.; Bouhnik, Y.; Tiret, E.; Kroesen, J.; Starlinger, M.; Mortensen, N. J. McM // Gut;Mar2006 Supplement, Vol. 55, pi16 

    This second section of the European Crohn's and Colitis Organisation (ECCO) Consensus on the management of Crohn's disease concerns treatment of active disease, maintenance of medically induced remission, and surgery. The first section on definitions and diagnosis includes the aims and methods...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics